Best Practices for Venous Sinus Stenting. Are we over-treating or under-treating patients?

This lecture reviews the results of Dr. Athos Patsalides’ publications in the field of Idiopathic Intracranial Hypertension (IIH). In this 1-hour webinar he discusses the “Best Practices for Venous Sinus Stenting. Are we over-treating or under-treating patients?”

Dr. Patsalides is a Neurointerventionalist at North Shore University and is Chief of NeuroInterventional Surgery at North Shore University Hospital, the flagship hospital of Northwell Health.He has pioneered novel treatments for IIH and pulsatile tinnitus and is an international expert in diagnosing and treating venous sinus stenosis.

Dr. Y. Pierre Gobin is an interventional neuroradiologist at Weill Cornell Medicine in New York. He is a pioneer in new and effective treatments for cerebral aneurysms and has developed and established minimally invasive surgical approaches to treat acute strokes and eye tumors.

Disclaimer: As of this webinar, no stent has been approved by the FDA for use in the venous sinuses of the brain. Therefore, venous sinus stenting is currently performed with stents used off-label. Neither IIH-Hub nor Serenity Medical, Inc. endorse the off-label usage of stents. The views expressed in this video are those of the speakers alone.

IIH—sometimes referred to as Pseudotumor Cerebri—is an underdiagnosed and undertreated disorder of elevated pressure within the brain without an identifiable cause. The IIH Practitioner Series is designed for neurologists, neurosurgeons, neuro-interventionalists, endovascular surgeons, interventionist radiologists, neuroradiologists, ophthalmologists, optometrists, and ENT specialists. Patients and caregivers are always welcome to attend.